Financial Metrics Unveiled: Amneal Pharmaceuticals Inc (AMRX)’s Key Ratios in the Spotlight

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

The price of Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed at $8.63 in the last session, down -2.04% from day before closing price of $8.81. In other words, the price has decreased by -$2.04 from its previous closing price. On the day, 1.08 million shares were traded. AMRX stock price reached its highest trading level at $8.9 during the session, while it also had its lowest trading level at $8.581.

Ratios:

We take a closer look at AMRX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.38.

Goldman Upgraded its Sell to Buy on March 08, 2021, whereas the target price for the stock was revised from $4 to $6.50.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Kiely John sold 17,058 shares for $8.38 per share. The transaction valued at 142,946 led to the insider holds 267,175 shares of the business.

Autor Deborah M. sold 33,229 shares of AMRX for $277,130 on Nov 22 ’24. The Director now owns 53,402 shares after completing the transaction at $8.34 per share. On Nov 21 ’24, another insider, Autor Deborah M., who serves as the Director of the company, sold 6,771 shares for $8.41 each. As a result, the insider received 56,944 and left with 86,631 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 3986723328 and an Enterprise Value of 5301113344. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.00. Its current Enterprise Value per Revenue stands at 1.978 whereas that against EBITDA is 9.353.

Stock Price History:

Over the past 52 weeks, AMRX has reached a high of $9.48, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 1.02%, while the 200-Day Moving Average is calculated to be 18.99%.

Shares Statistics:

According to the various share statistics, AMRX traded on average about 1.10M shares per day over the past 3-months and 1224580 shares per day over the past 10 days. A total of 309.77M shares are outstanding, with a floating share count of 126.53M. Insiders hold about 59.16% of the company’s shares, while institutions hold 41.90% stake in the company. Shares short for AMRX as of 1731628800 were 4482269 with a Short Ratio of 4.06, compared to 1728950400 on 4175093. Therefore, it implies a Short% of Shares Outstanding of 4482269 and a Short% of Float of 1.7399999999999998.

Most Popular